Investing
Acquisitions
Bristol-Myers Squibb Acquisitions decreased by 96.2% to $65.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.7%, from $78.00M to $65.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 25.1% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
High spending indicates an aggressive growth or diversification strategy, while low spending suggests a focus on organic growth or internal consolidation.
Detailed definition
This metric tracks the cash paid to acquire other businesses or business units, net of any cash acquired in the transact...
Peer comparison
Varies significantly based on M&A cycles; peers in the healthcare sector frequently use acquisitions to gain access to new diagnostic or therapeutic technologies.
Metric ID:
acquisitionsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $366.00M | $1.06B | $152.00M | $442.00M | $467.00M | $3.26B | $116.00M | $78.00M | $184.00M | $326.00M | $581.00M | $20.05B | $1.37B | $348.00M | $47.00M | $78.00M | $285.00M | $1.87B | $1.71B | $65.00M |
| QoQ Change | — | +188.8% | -85.6% | +190.8% | +5.7% | +598.3% | -96.4% | -32.8% | +135.9% | +77.2% | +78.2% | >999% | -93.2% | -74.7% | -86.5% | +66.0% | +265.4% | +557.5% | -8.9% | -96.2% |
| YoY Change | — | — | — | — | +27.6% | +208.5% | -23.7% | -82.4% | -60.6% | -90.0% | +400.9% | >999% | +646.2% | +6.7% | -91.9% | -99.6% | -79.2% | +438.5% | >999% | -16.7% |
Range$47.00M – $20.05B
CAGR-30.5%
Avg YoY Growth>999%
Median YoY Growth-5.0%
Current Streak2 quarters decline
Acquisitions at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's acquisitions?
- Bristol-Myers Squibb (BMY) reported acquisitions of $65.00M in Q1 2026.
- How has Bristol-Myers Squibb's acquisitions changed year-over-year?
- Bristol-Myers Squibb's acquisitions decreased by 16.7% year-over-year, from $78.00M to $65.00M.
- What is the long-term trend for Bristol-Myers Squibb's acquisitions?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's acquisitions has grown at a 25.1% compound annual growth rate (CAGR), from $1.61B to $3.94B.
- What does acquisitions mean?
- Cash spent to buy other companies or business units.